Shares of Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) were down 3.8% during mid-day trading on Tuesday . The stock traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during mid-day trading, a decline of 40% from the average daily volume of 644,760 shares. The stock had previously closed at C$0.27.
Emerald Health Therapeutics Stock Down 3.8 %
The stock has a 50-day moving average of C$0.26 and a 200-day moving average of C$0.26. The company has a debt-to-equity ratio of 35.45, a current ratio of 2.97 and a quick ratio of 2.61. The firm has a market cap of C$52.28 million and a price-to-earnings ratio of -0.37.
Emerald Health Therapeutics Company Profile
Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015.
Read More
- Five stocks we like better than Emerald Health Therapeutics
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Tech Leader’s Stock Split: Is It the Right Time to Buy?
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Could the Economy be Bottoming? Major Bank’s Earnings Say Yes
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Seize This Prime Stock Opportunity on Amazon Prime Days
Receive News & Ratings for Emerald Health Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emerald Health Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
